Targeted News Service

Pharmaceutical Firm Seeks Approval to Import Schedule I Substances for Research
February 26, 2025

WASHINGTON, Feb. 26 (TNSFR) -- Sharp Clinical Services, LLC has submitted an application to the Drug Enforcement Administration (DEA) seeking authorization to import several Schedule I controlled substances for clinical trials and distribution. Based in Bethlehem, Pennsylvania, the company aims to import Gamma Hydroxybutyric Acid (GHB), 3,4-Methylenedioxymethamphetamine (MDMA), 5-Methoxy-N-N-dimethyltryptamine (5-MeO-DMT), and psilocybin.

These substances, classified under the most . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form